Next-generation Sequencing Library Preparation Market

How Fast Is the NGS Library Preparation Market Growing?

The global next-generation sequencing library preparation market size is expected to be valued at US$ 2.18 billion in 2026 and projected to reach US$ 5.30 billion by 2033, growing at a CAGR of 13.5% between 2026 and 2033.

Between 2020 and 2025, the market grew at a CAGR of about 12.6%, boosted by pandemic-era viral sequencing and then sustained by oncology testing, population genomics, and single-cell research. Three factors now drive growth: falling sequencing costs that increase sample volumes, rapid adoption of clinical genomic testing, and new applications such as multi-omics and proteomics that need specialized library kits. The market is shifting toward faster, simpler, and automated workflows that reduce hands-on time and errors. Technologies that prepare libraries directly on sequencing flow cells could reshape the market in coming years.

• By Product: Reagents & Consumables held 82.4% share in 2026, while Automated Library Preparation Instruments are projected to expand at a 15.6% CAGR through 2033, driven by high-throughput labs seeking consistent results.
• By Sequencing Type: Targeted Sequencing held 52.6% share in 2026, while Whole Genome Sequencing is projected to expand at a 15.2% CAGR through 2033, driven by population genomics and rare disease diagnosis.
• By Library Type: DNA Library Preparation held 71.8% share in 2026, while RNA Library Preparation is projected to expand at a 14.9% CAGR through 2033, driven by single-cell and transcriptomics research.
• By End Use: Pharmaceutical & Biotechnology Companies held 36.2% share in 2026, while Hospitals & Clinics are projected to expand at a 16.1% CAGR through 2033, driven by in-house oncology and genetic testing.
• By Region: North America held 43.6% share in 2026, while Asia Pacific is projected to expand at a 15.8% CAGR through 2033, driven by genomics programs in China, India, and Japan.

Two drivers carry the strongest influence on NGS library preparation demand during the forecast period.

Rising Clinical Sequencing Volumes Are Driving NGS Library Preparation Demand

Rising sequencing volumes are the strongest driver of NGS library preparation demand. Every sample sequenced requires a library, so growth in tests and research projects directly increases kit consumption.

The mechanism is falling sequencing costs combined with wider clinical use. High-throughput systems such as Illumina’s NovaSeq X have cut whole-genome costs to a few hundred dollars, making large studies affordable. Oncology labs use comprehensive genomic profiling and liquid biopsy to guide cancer treatment, while hospitals sequence newborns and children with suspected rare diseases. Population programs such as UK Biobank and the All of Us program sequence hundreds of thousands of people. Infectious disease surveillance also continues. Targeted sequencing panels, which use hybridization capture or amplicon methods, remain the most common clinical approach, consuming large volumes of library and enrichment reagents.

Single-cell and Multi-omics Applications Are Expanding NGS Library Preparation Use

Single-cell, multi-omics, and proteomics applications are expanding NGS library preparation use. These newer applications require specialized kits that capture different molecules and preserve information about individual cells.

The cause is rapid growth in advanced biology research. Single-cell sequencing profiles gene activity in thousands of individual cells, helping researchers understand tumors, immune responses, and development. Spatial transcriptomics maps where genes are active in tissue. Epigenetic methods measure DNA methylation, which is important for cancer detection. In September 2025, Illumina launched Illumina Protein Prep, extending NGS-based workflows into proteomics. Each new application creates new and specialized library chemistry needs, such as barcoding, low-input amplification, and methylation conversion. Pharmaceutical companies, academic centers, and cancer research institutes adopt these methods to find new drug targets and biomarkers.

Two restraints limit how quickly NGS library preparation demand grows.

Workflow Complexity Limits NGS Library Preparation Adoption in Smaller Labs

Workflow complexity and skilled labor requirements limit NGS library preparation adoption, especially in smaller laboratories. Manual library preparation involves many precise steps, and errors can waste costly samples and sequencing runs.

The specific causes are multi-step protocols and quality control needs. Traditional workflows include DNA fragmentation, end repair, adapter ligation, amplification, cleanup, and quantification, which can take hours or days. Low-quality or low-quantity samples, such as formalin-fixed tissue or liquid biopsy, need specialized handling. Cross-contamination and index hopping can cause incorrect results. Labs need trained staff and quality systems, especially for clinical testing under CLIA and ISO 15189 standards. Automation platforms require capital investment and validation. These barriers lead smaller hospitals and labs in emerging markets to outsource testing to large reference laboratories instead of preparing libraries in-house.

Pricing Pressure and Funding Uncertainty Restrict NGS Library Preparation Growth

Pricing pressure and research funding uncertainty restrict NGS library preparation market growth. Kits are a large share of per-sample costs, so labs constantly seek cheaper options.

The underlying causes are competition and budget constraints. Low-cost sequencing platforms from companies such as Element Biosciences, Ultima Genomics, and MGI Tech push down total costs and pressure kit prices. Chinese suppliers offer cheaper reagents in domestic and export markets. Large customers negotiate volume discounts or develop in-house methods. Academic research depends on government grants, and changes in funding, such as proposed cuts to National Institutes of Health budgets in the United States in 2025, create uncertainty for purchasing. Trade tensions, including China’s placement of Illumina on its unreliable entity list in 2025, also disrupt supply. These factors slow revenue growth even as sample volumes rise.

Automation and On-instrument Library Preparation Open a Workflow Revenue Pool

Automation and on-instrument library preparation open a workflow revenue pool in the NGS library preparation market. Labs want sample-to-answer workflows with less hands-on time and fewer errors.

Instrument makers and kit suppliers that integrate automation can capture this demand. Liquid handlers and dedicated systems prepare dozens or hundreds of libraries per run. In May 2024, SPT Labtech and Watchmaker Genomics partnered to automate library preparation on the firefly platform. In February 2025, Illumina described its constellation mapped read technology, now called TruPath Genome, which prepares libraries directly on the flow cell in about 10 to 15 minutes after extraction. Library preparation automation appeals to clinical labs, biobanks, and contract sequencing providers. Bundled instruments, validated kits, and software create recurring revenue and stronger customer loyalty.

Clinical Oncology and Liquid Biopsy Create a High-Value Kit Revenue Pool

Clinical oncology and liquid biopsy create a high-value kit revenue pool for NGS library preparation. Cancer testing requires sensitive, validated kits that can detect rare mutations in small amounts of DNA.

Suppliers with regulatory-grade kits and strong clinical evidence can capture this opportunity. Liquid biopsy tests detect tumor DNA in blood, enabling cancer screening, treatment selection, and monitoring for recurrence. These tests need library methods with molecular barcodes to reduce errors. Comprehensive genomic profiling panels for solid tumors guide targeted therapy decisions. Thermo Fisher Scientific launched the Oncomine Comprehensive Assay Plus on its Genexus System in July 2025. Hospitals, reference labs, and companies such as Guardant Health and Foundation Medicine are key users. Regulatory approval and clinical validation create high entry barriers and support premium pricing for established suppliers.

By Product: Reagents & Consumables Lead While Automated Library Preparation Instruments Gain Momentum

Reagents & Consumables held 82.4% share in 2026. Every library requires enzymes, adapters, barcodes, beads, and buffers, so kits generate recurring revenue with each sample. Illumina, Thermo Fisher Scientific, Agilent, QIAGEN, Roche, and New England Biolabs offer broad kit portfolios.

Automated Library Preparation Instruments are the fastest-growing product, expanding at a 15.6% CAGR through 2033. High-throughput labs use liquid handlers and dedicated systems to prepare many libraries consistently, reducing labor and errors. Clinical labs need reproducible workflows for accreditation. Microfluidic and integrated systems combine extraction, library preparation, and sequencing. Suppliers such as Hamilton, Beckman Coulter, SPT Labtech, and Revvity provide platforms. For the market, instrument growth deepens customer relationships and increases kit pull-through on automated systems.

By Sequencing Type: Targeted Sequencing Leads While Whole Genome Sequencing Grows Fastest

Targeted Sequencing held 52.6% share in 2026. Gene panels and exome capture focus on clinically relevant regions, lowering sequencing costs and simplifying interpretation. Oncology, inherited disease, and infectious disease testing rely heavily on targeted methods.

Whole Genome Sequencing is the fastest-growing sequencing type, expanding at a 15.2% CAGR through 2033. Lower sequencing costs make whole genomes affordable for population programs, rare disease diagnosis, and research. Whole genomes detect structural variants and non-coding changes missed by panels. National programs in the United Kingdom, United States, Saudi Arabia, and Singapore are sequencing large populations. Simple tagmentation kits speed whole-genome library preparation. For the market, whole-genome growth increases volumes of PCR-free and high-throughput library kits.

By Library Type: DNA Library Preparation Leads While RNA Library Preparation Grows Fastest

DNA Library Preparation held 71.8% share in 2026. DNA libraries support whole-genome, exome, targeted panel, methylation, and liquid biopsy testing, which make up most clinical and research sequencing.

RNA Library Preparation is the fastest-growing library type, expanding at a 14.9% CAGR through 2033. RNA sequencing measures gene expression, detects fusion genes in cancer, and supports single-cell and spatial studies. Single-cell platforms and RNA-based biomarker discovery increase demand for low-input and barcoded RNA kits. Drug developers use transcriptomics to understand drug responses and toxicity. Methylation, immune repertoire, and multi-omics libraries are also growing quickly. For the market, RNA growth supports higher-value specialized kits and links library preparation to advanced research applications.

By End Use: Pharmaceutical & Biotechnology Companies Lead While Hospitals & Clinics Grow Fastest

Pharmaceutical & Biotechnology Companies held 36.2% share in 2026. Drug developers use NGS for target discovery, biomarker development, clinical trial patient selection, and cell and gene therapy quality control, consuming large volumes of library kits.

Hospitals & Clinics are the fastest-growing end use, expanding at a 16.1% CAGR through 2033. More hospitals are bringing oncology, inherited disease, and infectious disease testing in-house to shorten turnaround times. Benchtop sequencers and automated workflows make this practical for mid-sized labs. Reimbursement for genomic testing is expanding in many countries, including Medicare coverage for tumor profiling. Academic research institutes and contract research organizations remain major, steady users. For the market, hospital growth increases demand for validated, easy-to-use kits with regulatory approvals.

Which Region Is Leading the Next-generation Sequencing Library Preparation Market?

North America is leading the next-generation sequencing library preparation market with a 43.6% share in 2026. The United States has the largest genomics research base, major sequencing companies such as Illumina and Thermo Fisher Scientific, and many clinical testing labs. Programs such as All of Us and large cancer centers generate high sample volumes. Reimbursement for comprehensive genomic profiling supports oncology testing. Pharmaceutical companies and biotech hubs in Boston and San Francisco use NGS heavily. Canada adds research demand through Genome Canada programs and provincial cancer agencies. One change shaping the region is the spread of in-house hospital sequencing.

Europe Expands NGS Library Preparation Through National Genomic Medicine Programs

Europe is a major NGS library preparation market supported by national genomic medicine programs. England’s NHS Genomic Medicine Service offers whole-genome sequencing for rare diseases and cancers. Germany, France, and the Netherlands invest heavily in precision oncology networks and biobanks. The European 1+ Million Genomes initiative promotes cross-border genomic data sharing. QIAGEN in Germany and Roche in Switzerland are major suppliers of kits and panels. The In Vitro Diagnostic Regulation raises evidence and quality requirements for clinical kits, favoring larger suppliers with regulatory expertise. Public tenders keep prices competitive. One opportunity is regulatory-compliant kits for hospital oncology labs.

Which Region Is Growing Fastest in the Next-generation Sequencing Library Preparation Market?

Asia Pacific is growing fastest in the next-generation sequencing library preparation market at a 15.8% CAGR through 2033. China has large sequencing capacity through BGI Genomics and MGI Tech, along with domestic kit suppliers. India’s GenomeIndia project and growing private diagnostics labs increase demand. Japan and South Korea run national cancer genome and biobank programs, and Singapore invests in precision medicine. Trade tensions shape supplier choices in China, where hospitals increasingly prefer domestic sequencing platforms and kits. Contract research organizations across the region also add sequencing capacity. One opportunity is lower-cost kits for fast-growing clinical labs.

Latin America Builds NGS Library Preparation Demand Through Oncology and Research

Latin America is an emerging NGS library preparation market where oncology testing and academic research drive demand. Brazil and Mexico have the region’s largest genomics labs, including private diagnostic companies offering cancer, prenatal, and inherited disease tests. Argentina, Chile, and Colombia have research institutes using NGS for agriculture, aquaculture, pathogens, and human genetics. Key barriers include high import costs, currency volatility, limited reimbursement, and reliance on a few centralized labs in major cities. Many samples are still sent abroad for complex testing, which delays results. One clear opportunity is distributed testing using affordable benchtop sequencers and simplified kits.

Middle East & Africa Grows NGS Library Preparation Use Through National Genome Programs

Middle East & Africa is a developing NGS library preparation market where national genome programs drive demand. The Saudi Genome Program, Emirati Genome Programme, and Qatar Genome Programme have sequenced large numbers of citizens, creating high kit demand. Hospitals in the Gulf are adding in-house oncology, newborn, and rare disease testing. In Africa, South Africa, Kenya, and Nigeria use sequencing for pathogen surveillance and research. Key barriers include limited laboratory infrastructure, cold chain challenges for reagents, and shortages of trained genomics staff outside major centers. One opportunity is genomic studies of underrepresented African populations.

The NGS library preparation market is moderately concentrated. Illumina, Thermo Fisher Scientific, Agilent Technologies, QIAGEN, and Roche lead with broad kit portfolios and links to sequencing platforms. New England Biolabs, Integrated DNA Technologies, Twist Bioscience, Watchmaker Genomics, Takara Bio, and 10x Genomics compete in specialized chemistries and applications, while MGI Tech and Chinese suppliers grow in Asia Pacific.

Companies compete on workflow speed, input flexibility, data quality, automation compatibility, regulatory status, and price. Platform-agnostic kits appeal to labs using multiple sequencers, while platform makers bundle optimized kits with instruments. Targeted enrichment panels, molecular barcoding, and low-input methods differentiate suppliers in clinical markets. Startups such as Watchmaker Genomics compete on enzyme engineering and faster protocols, while open-source and homemade methods remain common in large genome centers seeking lower costs.

Strategic moves show how competition is changing. In May 2024, SPT Labtech and Watchmaker Genomics partnered to automate library preparation. In February 2025, Illumina described on-flow-cell library preparation that could greatly simplify workflows. In July 2025, Thermo Fisher Scientific launched the Oncomine Comprehensive Assay Plus on the Genexus System. In September 2025, Illumina launched Illumina Protein Prep, extending library workflows into proteomics. These moves show competition shifting toward automation, integrated workflows, and new applications.

Three themes shape vendor strategy. First, companies are simplifying and automating workflows. Second, they are developing clinical-grade kits. Third, they are expanding into multi-omics applications.

Next-generation Sequencing Library Preparation Market Industry Leaders

• Illumina
• Thermo Fisher Scientific
• Agilent Technologies
• QIAGEN
• Roche

Recent Industry Developments

September 2025: Illumina launched Illumina Protein Prep for NGS-based proteomics - extends library preparation into protein analysis.

July 2025: Thermo Fisher Scientific launched the Oncomine Comprehensive Assay Plus on the Genexus System - strengthens automated oncology workflows.

February 2025: Illumina described its constellation mapped read technology for on-flow-cell library preparation - could transform library workflows.

May 2024: SPT Labtech and Watchmaker Genomics partnered on automated library preparation - expands walk-away workflows.

This report covers products used to prepare DNA and RNA libraries for next-generation sequencing, including reagents, kits, enrichment panels, and automated library preparation instruments, across targeted, whole-exome, and whole-genome sequencing. It excludes sequencing instruments and flow cells, nucleic acid extraction kits, and sequencing services. The base year is 2025, and the forecast period runs from 2026 to 2033. All values are expressed in US$ Billion.

Product

• Reagents & Consumables
• Automated Library Preparation Instruments

Sequencing Type

• Targeted Sequencing
• Whole Exome Sequencing
• Whole Genome Sequencing

Library Type

• DNA Library Preparation
• RNA Library Preparation

End Use

• Pharmaceutical & Biotechnology Companies
• Hospitals & Clinics
• Academic & Research Institutes
• Contract Research Organizations

Regions

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa